📰 Lorem Foundation News
Lorem Foundation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lorem Foundation. Real-time updates on events, politics, business and more.
March 24, 2024
An ultra-rare genetic mutation has seven-year-old Sasha Lipworth regressing into infancy. Her diagnosis this month gives her a front-row seat to the future of medicine.
March 24, 2024
An ultra-rare genetic mutation has seven-year-old Sasha Lipworth regressing into infancy. Her diagnosis this month gives her a front-row seat to the future of medicine.
March 24, 2024
An ultra-rare genetic mutation has seven-year-old Sasha Lipworth regressing into infancy. Her diagnosis this month gives her a front-row seat to the future of medicine.
December 20, 2023
N-Lorem delivers on its promises with six nano-rare patients treated, ten INDs filed, and more personalized optimized treatments on the horizonAnnual letter unveils n-Lorem’s achievements and progress in the past yearSAN DIEGO--(BUSINESS WIRE)--#ASO--n-Lorem, a nonprofit Foundation, outlines the exceptional progress...
October 12, 2023
/PRNewswire/ -- The "Next Generation Drug Conjugates Market: Distribution by Type of Targeting Ligand, Type of Payload, Type of Therapy, Route of...
October 12, 2023
Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The
October 11, 2023
Hosted by Biogen, the one-day summit brings together patients, physicians, partners and supporters to create a strong, cohesive, empathetic and knowledgeable nano-rare community.n-Lorem has made tremendous progress over the last four years to develop optimized, personalized ASO medicines for nano-rare patients and p...
October 8, 2023
Antisense oligonucleotides (ASOs) have faced their share of challenges, but a combination of research advances and a market ripe for innovation is setting this drug class up for a resurgence. Antisense oligonucleotide (ASO)—a class of drugs that works by targeting RNA to alter gene expression and control aberrant proteins in ways that traditional drugs can’t.
May 11, 2023
The first draft of the pangenome is based on the full genetic blueprints of 47 people from around the world
March 2, 2023
Newest members bolster scientific and financial expertise as the Foundation expands to meet an increasing demand from the nano-rare communitySAN DIEGO--(BUSINESS WIRE)--#ASO--n-Lorem a nonprofit Foundation, discovering, developing and providing experimental antisense oligonucleotides (ASOs) medicines to nano-rare pa...